The immunopathology of liver granulomas in primary biliary cirrhosis

Journal of Autoimmunity

Volumn 39, Issue 3, 2012, Pages 216-221

  You, Zhengrui ^a   Wang, Qixia ^a   Bian, Zhaolian ^a   Liu, Yuan ^a   Han, Xiaofeng ^a   Peng, Yanshen ^a   Shen, Lei ^a   Chen, Xiaoyu ^a   Qiu, Dekai ^a   Selmi, Carlo ^b,c   Gershwin, M Eric ^b   Ma, Xiong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

B cell; CD11c; Dendritic cell; Granuloma; Immunoglobulin M

Indexed keywords

CD83 ANTIGEN; CHEMOKINE RECEPTOR CCR7; COMPLEMENT COMPONENT C1Q; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN M; INTERLEUKIN 23; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL MATURATION; DENDRITIC CELL; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LIVER GRANULOMA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PLASMA CELL; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; DENDRITIC CELLS; FEMALE; GRANULOMA; HUMANS; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS, BILIARY; MACROPHAGES; MALE; MIDDLE AGED; PLASMA CELLS;

EID: 84865393551     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.05.022     Document Type: Article

References (42)

1. Selmi C., Bowlus C.L., Gershwin M.E., Coppel R.L. Primary biliary cirrhosis. Lancet 2011, 377:1600-1609.
2. Lindor K.D., Gershwin M.E., Poupon R., Kaplan M., Bergasa N.V., Heathcote E.J. Primary biliary cirrhosis. Hepatology 2009, 50:291-308.
3. Kikuchi K., Lian Z.X., Yang G.X., Ansari A.A., Ikehara S., Kaplan M., et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 2005, 128:304-312.
4. Drebber U., Mueller J.J., Klein E., Kasper H.U., Schulze F., Schardt K., et al. Liver biopsy in primary biliary cirrhosis: clinicopathological data and stage. Pathol Int 2009, 59:546-554.
5. Lagana S.M., Moreira R.K., Lefkowitch J.H. Hepatic granulomas: pathogenesis and differential diagnosis. Clin Liver Dis 2010, 14:605-617.
6. Tsuneyama K., Yasoshima M., Harada K., Hiramatsu K., Gershwin M.E., Nakanuma Y. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology 1998, 28:620-623.
7. Harada K., Tsuneyama K., Sudo Y., Masuda S., Nakanuma Y. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation?. Hepatology 2001, 33:530-536.
8. Vergani D., Mieli-Vergani G. Cutting edge issues in autoimmune hepatitis. Clin Rev Allergy Immunol 2011.
9. Ludwig J., Dickson E.R., McDonald G.S. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978, 379:103-112.
10. Carotta S., Dakic A., D'Amico A., Pang S.H., Greig K.T., Nutt S.L., et al. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 2010, 32:628-641.
11. Almadi M.A., Aljebreen A.M., Sanai F.M., Marcus V., Almeghaiseeb E.S., Ghosh S. New insights into gastrointestinal and hepatic granulomatous disorders. Nat Rev Gastroenterol Hepatol 2011, 8:455-466.
12. Lefkowitch J.H. Hepatic granulomas. J Hepatol 1999, 30(Suppl. 1):40-45.
13. Drebber U., Kasper H.U., Ratering J., Wedemeyer I., Schirmacher P., Dienes H.P., et al. Hepatic granulomas: histological and molecular pathological approach to differential diagnosis-a study of 442 cases. Liver Int 2008, 28:828-834.
14. Dourakis S.P., Saramadou R., Alexopoulou A., Kafiri G., Deutsch M., Koskinas J., et al. Hepatic granulomas: a 6-year experience in a single center in Greece. Eur J Gastroenterol Hepatol 2007, 19:101-104.
15. Turhan N., Kurt M., Ozderin Y.O., Kurt O.K. Hepatic granulomas: a clinicopathologic analysis of 86 cases. Pathol Res Pract 2011, 207:359-365.
16. Lleo A., Liao J., Invernizzi P., Zhao M., Bernuzzi F., Ma L., et al. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 2012, 55:153-160.
17. Sumpter T.L., Abe M., Tokita D., Thomson A.W. Dendritic cells, the liver, and transplantation. Hepatology 2007, 46:2021-2031.
18. Hosszu K.K., Santiago-Schwarz F., Peerschke E.I., Ghebrehiwet B. Evidence that a C1q/C1qR system regulates monocyte-derived dendritic cell differentiation at the interface of innate and acquired immunity. Innate Immun 2010, 16:115-127.
19. Mizoguchi A., Ogawa A., Takedatsu H., Sugimoto K., Shimomura Y., Shirane K., et al. Dependence of intestinal granuloma formation on unique myeloid DC-like cells. J Clin Invest 2007, 117:605-615.
20. Schreiber HA, Hulseberg PD, Lee J, Prechl J, Barta P, Szlavik N, et al. Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model. PLoS One; 5: e11453.
21. Castellano G., Woltman A.M., Nauta A.J., Roos A., Trouw L.A., Seelen M.A., et al. Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood 2004, 103:3813-3820.
22. Castellano G., Trouw L.A., Fiore N., Daha M.R., Schena F.P., van Kooten C. Infiltrating dendritic cells contribute to local synthesis of C1q in murine and human lupus nephritis. Mol Immunol 2010, 47:2129-2137.
23. Duarte-Rey C., Bogdanos D.P., Leung P.S., Anaya J.M., Gershwin M.E. IgM predominance in autoimmune disease: genetics and gender. Autoimmun Rev 2011.
24. Baumgarth N., Tung J.W., Herzenberg L.A. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 2005, 26:347-362.
25. Klimovich V.B. IgM and its receptors: structural and functional aspects. Biochemistry (Mosc) 2011, 76:534-549.
26. Takahashi T., Miura T., Nakamura J., Yamada S., Miura T., Yanagi M., et al. Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis. Hepatology 2012, 55:846-855.
27. Dhirapong A., Lleo A., Yang G.X., Tsuneyama K., Dunn R., Kehry M., et al. B cell depletion therapy exacerbates murine primary biliary cirrhosis. Hepatology 2011, 53:527-535.
28. Tsuda M., Moritoki Y., Lian Z.X., Zhang W., Yoshida K., Wakabayashi K., et al. Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Hepatology 2012, 55:512-521.
29. Lleo A., Shimoda S., Ishibashi H., Gershwin M.E. Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes. J Gastroenterol 2011, 46(Suppl. 1):29-38.
30. Lleo A., Bowlus C.L., Yang G.X., Invernizzi P., Podda M., Van de Water J., et al. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology 2010, 52:987-998.
31. Lleo A., Selmi C., Invernizzi P., Podda M., Coppel R.L., Mackay I.R., et al. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 2009, 49:871-879.
32. Kushwah R., Wu J., Oliver J.R., Jiang G., Zhang J., Siminovitch K.A., et al. Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. Eur J Immunol 2010, 40:1022-1035.
33. Quintero O.L., Amador-Patarroyo M.J., Montoya-Ortiz G., Rojas-Villarraga A., Anaya J.M. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012, 38:J109-J119.
34. Shoenfeld Y., Tincani A., Gershwin M.E. Sex gender and autoimmunity. J Autoimmun 2012, 38:J71-J73.
35. Grossman C., Dovrish Z., Shoenfeld Y., Amital H. Do infections facilitate the emergence of systemic sclerosis?. Autoimmun Rev 2011, 10:244-247.
36. Shapira Y., Poratkatz B.S., Gilburd B., Barzilai O., Ram M., Blank M., et al. Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults. Clin Rev Allergy Immunol 2012, 42:154-163.
37. Meron M.K., Amital H., Shepshelovich D., Barzilai O., Ram M., Anaya J.M., et al. Infectious aspects and the etiopathogenesis of rheumatoid arthritis. Clin Rev Allergy Immunol 2010, 38:287-291.
38. Tian L., De Hertogh G., Fedeli M., Staats K.A., Schonefeldt S., Humblet-Baron S., et al. Loss of T cell microRNA provides systemic protection against autoimmune pathology in mice. J Autoimmun 2012, 38:39-48.
39. Mackay I.R., Leskovsek N.V., Rose N.R. The odd couple: a fresh look at autoimmunity and immunodeficiency. J Autoimmun 2010, 35:199-205.
40. Gershwin M.E., Shoenfeld Y. Chella David: a lifetime contribution in translational immunology. J Autoimmun 2011, 37:59-62.
41. Rose N.R. The genetics of autoimmune thyroiditis: the first decade. J Autoimmun 2011, 37:88-94.
42. Youinou P., Haralampos M. Moutsopoulos: a lifetime in autoimmunity. J Autoimmun 2010, 35:171-175.